The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...
A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said ...
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...
Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...
Prostate Cancer Awareness Month 2025: September is the month of Prostate Cancer Awareness. Which is one of the most commonly detected cancers in men. Its time to bring prostate cancer into the ...
A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...
Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up For Black men, and those who love them, it is essential that you ...
Prostate cancer has been one of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results